Differential response to a 6-month energy-restricted treatment depending on SH2B1 rs7359397 variant in NAFLD subjects: Fatty Liver in Obesity (FLiO) Study.

Nuria Pérez Diaz Del Campo Bertha Araceli Marin-Alejandre Irene CanteroJ Ignacio MonrealMariana ElorzJosé Ignacio Herrero Alberto Benito José-Ignacio Riezu-Boj Fermin Ignacio Milagro Josep Antonio Tur José Alfredo Martínez Hernández José Alfredo Martínez María de Los Ángeles Zulet

Published in: European journal of nutrition (2021)

The Fatty Liver in Obesity was approved by the Research Ethics Committee of the University of Navarra and retrospectively registered (NCT03183193; www.clinicaltrials.gov ); June 2017.

Keyphrases

insulin resistance
metabolic syndrome
weight loss
high fat diet induced
type diabetes
weight gain
public health
fatty acid
big data
adipose tissue
body mass index
artificial intelligence
smoking cessation